Non-Invasive Fat Reduction Market

Global Non-invasive Fat Reduction Market Size (2024 to 2029)

The global non-invasive fat reduction market is predicted to be worth USD 3.30 Billion by 2029, growing at a CAGR of 14.5% between 2024 and 2029. Non-surgical fat reduction is also well-known as Non-invasive fat reduction.

Non-surgical fat reduction requires minimally invasive procedures that break down fat cells selectively in specific places to shrink subcutaneous fat pockets. There are a variety of FDA-approved therapies that achieve steady, moderate fat loss without surgery or downtime. Low-level laser therapy (LLLT), cryolipolysis, radio frequency (R.F.), and high-intensity centered ultrasound are the four most common non-invasive techniques for reducing localized subcutaneous adipose tissue (HIFU). The healthcare sector is rapidly evolving. Non-invasive procedures are getting popular, and each technique differs in terms of its benefits and the severity of its drawbacks. However, a variety of non-invasive devices are both safe and effective. Because of the risks, financial costs, and lengthy downtime associated with surgical procedures for fat reduction, many non-invasive techniques have been developed. The practitioner must select the appropriate product, perform the proper treatment method, and cure with the skill to avoid any negative impacts. There are numerous non-invasive body contouring modalities available today.

MARKET DRIVERS

The growing patient population suffering from obesity worldwide primarily boosts the non-invasive fat reduction market growth.

The number of people suffering from obesity is on the rise worldwide. An estimated 13% of the population worldwide are obese currently. WHO says 39 million children aged below 5 years were overweight or obese in 2020. Obesity can lead to severe health difficulties such as cardiovascular disease, type 2 diabetes, and certain types of cancer if not handled effectively. People that suffer from obesity struggle with weight loss and find it difficult to achieve their desired body shape through diet and exercise alone. Non-invasive fat reduction is an effective alternative for obese people in such situations. Non-invasive fat reduction is effective, safe and has minimal downtime. The awareness regarding the benefits and effectiveness of non-invasive fat reduction among the patient population of obesity has significantly improved in recent years. This trend is likely to continue in the coming years and boost the market growth.

Technological advancements further fuel the growth rate of the non-invasive fat reduction market. The non-invasive fat reduction market has experienced several technological upgrades in recent years. The market participants have developed novel non-invasive fat reduction technologies such as Cryolipolysis and ultrasound-based devices in recent years. These technologies have been effective in treating the conditions and gained the acceptance of the patient population. These technologies are further believed to be delivering significant fat reduction, improved body contouring and increased self-confidence. Due to these advantages, patients who undergo these treatments are most likely to share their experiences with others and recommend these procedures.

The growing demand for non-surgical procedures by people due to the associated benefits such as being less invasive, having shorter recovery times, and carrying fewer risks is another major factor propelling the market growth. The rising popularity of cosmetic procedures, growing disposable income, increasing focus on appearance and body image by people and increasing availability of non-invasive fat reduction procedures further contribute to the market growth. The rising trend of men seeking out cosmetic procedures, high patient satisfaction rates of non-invasive fat reduction procedures, growing adoption of non-invasive fat reduction procedures by aesthetic clinics and increasing popularity of combination therapies further support the market growth.

MARKET RESTRAINTS

High costs associated with the non-invasive fat reduction procedures is one of the major factors hampering the market growth. Limited effectiveness of non-invasive fat reduction procedures for some patients and risks and side effects of non-invasive fat reduction procedures such as pain, swelling and bruising further inhibit the market growth. The competition from other cosmetic procedures, such as liposuction and lack of regulation policies for non-invasive fat reduction procedures further impede the market growth.

REPORT COVERAGE

SEGMENTAL ANALYSIS

Non-invasive Fat Reduction Market By Technology

The cryolipolysis segment is expected to dominate the market during the forecast period due to the advantages of the procedure. Cryolipolysis is a cold body countering procedure where the fat in the body is frozen and then slowly removed from the body in 2 to 6 months. The procedure is non-invasive and has very few side effects associated with it. Additionally, cryolipolysis is an affordable procedure, and the campaigns about the procedure's feasibility are expected to boost the market's revenue. 

However, the low-level laser segment is also expected to have significant revenue during the forecast period due to targeting cells and permanently eradicating them from the body. In addition, the low-level laser uses multiple sittings to reduce fat over time entirely and, with fewer side effects, non-invasive procedures. 

Non-invasive Fat Reduction Market By End Users

Based on the end-users, the hospital segment is expected to have the largest share in the global non-invasive fat reduction market during the forecast period owing to secure access to physicians who conduct a wide range of medical aesthetic fat reduction treatments. As a result, hospitals have a large influx of patients and more credibility among the population. In addition, hospitals have advanced infrastructures and technologies and well-trained professionals to assist the patients, leading to more revenue for the segment. 

However, the dermatology clinics segment is also expected to show progress in the market due to the recent increase in the inclusion of body care in salons, spas, and dermatological care centers. In addition, the rising locations of dermatology clinics due to increased demand for personal care and aesthetic appearance growth is expected to boost the segment after the hospitals.

REGIONAL ANALYSIS

Regionally, the North American non-invasive fat reduction market had the leading share of the global market in 2022, followed by Europe. However, the Asia Pacific is to witness significant growth. The dominance of the North American market can be attributed to the rising demand for fat-reduction therapies in countries like the U.S. and Canada, owing to rising cases of obesity. The region is also growing due to investments from key market players and disposable income increases. Additionally, the improved infrastructure for the healthcare sector is expected to dominate the market. 

The European non-invasive fat reduction market is expected to show significant growth during the forecast period due to rising awareness about appearance and the rapid adoption of the latest technologies like cold sculpting body contouring in countries like the U.K., Germany, Italy, France, etc. The growing awareness of aesthetic treatments, a well-established cosmetic industry, the rising prevalence of obesity, the increasing desire for non-surgical alternatives, and the availability of advanced fat reduction technologies in Europe contribute to the European market growth. The presence of skilled healthcare professionals and a favorable reimbursement environment fuels the growth rate of the European market.

The Asia-Pacific non-invasive fat reduction market is estimated to grow at a promising CAGR during the forecast period owing to the growing adoption of the Western concept of aesthetic appearance in countries like India, China, Japan, South Korea and others. Furthermore, the efforts of the market players in the region and the low cost of procedures support the market growth in the Asia-Pacific region. The growing disposable income, changing lifestyle patterns and a rising emphasis on physical appearance, rising demand for non-invasive fat reduction procedures in China, Japan and South Korea, large population base, the growing awareness of aesthetic treatments and the expanding medical tourism industry in the region further boost the growth rate of the APAC market.

The non-invasive fat reduction market in Latin America is expected to grow at a steady CAGR during the forecast period. Factors such as the high prevalence of obesity, an increasing emphasis on body contouring and aesthetic treatments, rising disposable income, growing beauty consciousness and advancements in cosmetic procedures primarily drive the non-invasive fat reduction market growth in Latin America. Favorable government policies and the presence of aesthetic clinics and wellness centers further drive the Latin American market growth.

The non-invasive fat reduction market in the Middle East and Africa is also expected to grow. Still, the revenue is hindered by some countries' lack of awareness and low economic stability. 

KEY MARKET PARTICIPANTS

Some promising companies leading the global non-invasive fat reduction market profiled in the report are Fosun Pharmaceutical Co., Ltd, Cutera, Inc., BTL Industries, Invasix Aesthetic Solutions, Cynosure, Inc., ZELTIQ Aesthetics, Inc., Solta Medical, Syneron Medical Ltd, and Venus Concept.

RECENT MARKET HAPPENINGS

• In November 2022, Madrigal Pharmaceuticals, a biotechnology company, is all set to announce its 3rd quarter financial results and the results of the resmetirom at the AASLD Liver Meeting. The data presented would target the results toward the resmetiroms effectiveness in treating the patients of NASH cirrhosis. In addition, a positive response from the clinical studies would allow the company to further its research and develop a drug based on the research results. 
• In November 2022, Phase 2b clinical trials (FASCINATE-2) with denifanstat showed positive interim results for the clinical biotechnology company segment biosciences. Denifanstat (2640), a fatty acid synthase (FASN) inhibitor in non-alcoholic steatohepatitis patients, has been proven to help treat NAHS patients.
• In October 2022, Renew ND, a spa in Washington D.C., announced that it will now be providing EON technology based on the heat laser technology used to naturally eliminate fats through lymphatic systems with the help of robotic systems. This system is designed to assist patients in achieving a non-invasive body contouring treatment after fat reduction procedures. 
• In November 2022, LipoAI, a piece of technologically advanced equipment designed as a better alternative to liposuction, is a minimally invasive and safe process of body contouring for fat reduction. The technology has been introduced by Cartessa, a renowned non-invasive aesthetic technologies producer closely associated with DEKA, an Italian manufacturer.

DETAILED SEGMENTATION OF THE GLOBAL NON-INVASIVE FAT REDUCTION MARKET INCLUDED IN THIS REPORT

This market research report on the global non-invasive fat reduction market has been segmented and sub-segmented based on technology, end-user, and region.

By Technology     

• Cryolipolysis      
• Low-Level Lasers  
• Ultrasound

By End Users

• Cosmetic Centers  
• Dermatology Clinics       
• Hospitals

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa